News & Analysis as of

Injunctions › Apotex

Patterson Belknap Webb & Tyler LLP

Apotex Prevails in Neulasta Biosimilar Litigation, Files for Cert on 180-Day Issue

Patterson Belknap Webb & Tyler LLP on

Among the first generation of biosimilar litigation under the Biologics Price Competition and Innovation Act (BPCIA) is a dispute between Amgen and Apotex over Apotex’s proposed biosimilar versions of Amgen’s Neupogen...more

1 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide